Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Immune Checkpoint Inhibitor-Induced Scleroderma-Like Pulmonary Fibrosis in a Patient With Advanced Lung Cancer: A

Juan O Rodriguez Padilla1, Yatin Kheti2, Felix Carrillo3

  • 1Internal Medicine, Lakeland Regional Health, Lakeland, USA.

Cureus
|May 26, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ascending Aortic Graft Anastomotic Thrombosis Mimicking Prosthetic Graft Endocarditis.

Cureus·2026
Same author

Revascularization of radial artery for ischemic hand with history of hand reimplantation.

Journal of vascular surgery cases and innovative techniques·2024
Same author

Definition and Perception of Autonomy in Vascular Surgery Training.

Annals of vascular surgery·2024
Same author

Extra-anatomic bypass can treat renovascular hypertension due to atherosclerotic atypical aortic coarctation.

Journal of vascular surgery cases and innovative techniques·2023
Same author

Leadership skills curriculum development for residents and fellows: A needs-assessment.

American journal of surgery·2021

A rare scleroderma-like autoimmune syndrome may develop after immune checkpoint inhibitor therapy for non-small cell lung cancer. This case highlights the importance of considering autoimmune causes for respiratory decline post-immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Pulmonology

Background:

  • Immune checkpoint inhibitors (ICIs) like pembrolizumab are crucial in treating non-small cell lung cancer (NSCLC).
  • ICI therapy can induce various immune-related adverse events (irAEs).
  • Rarely, ICIs may trigger or unmask autoimmune conditions.
Keywords:
autoimmune pneumonitisimmune checkpoint inhibitorsinterstitial lung diseasepembrolizumabpulmonary fibrosisscleroderma-like syndrome

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Experiment Videos

Last Updated: May 27, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024